Cipla informs about press release

12 Aug 2021 Evaluate

Cipla has informed that it enclosed press release dated 12th August 2021, titled ‘Cipla receives final approval for generic version of Novartis Pharmaceuticals Corporation Durezol® (Difluprednate Ophthalmic Emulsion 0.05%’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1311.35 -16.90 (-1.27%)
29-Jan-2026 10:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.35
Dr. Reddys Lab 1196.70
Cipla 1311.35
Zydus Lifesciences 883.50
Lupin 2099.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×